Recent case study highlights the importance of applying statistical rigor throughout the development and validation processes of biomarkers.
Elisabeth Coart, PhD
Advertisement
Articles by Elisabeth Coart, PhD
Applied Clinical Trials
The development and qualification of biomarkers are keys to the future of drug development and precision medicine, particularly in oncology.
Advertisement
Latest Updated Articles
- Integration of Biomarker Validation in Oncology Trials
August 13th 2020
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Data Harmonization Imperative: How AI Is Solving Clinical Research's Biggest Bottleneck
2
SCOPE X: The COPD Case Study That Shows What AI Can Do for Enrollment
3
A Shot in the Arm to Traditional Vaccine Trial Strategy
4
SCOPE X: How AI Could Reshape the Sponsor-Site Relationship Over the Next Several Years
5